Influenza News and Research

Latest Influenza News and Research

Low acceptance of COVID-19 vaccine among healthcare workers in USA

A recent preprint research paper published on the medRxiv server in January 2021 reports that vaccine acceptance is low even among healthcare workers (HCWs) in the USA.

6 Jan 2021

Scientists develop a new method to study the molecular characteristics of T cells

UT Southwestern scientists have developed a new method to study the molecular characteristics of T cells, critical immune cells that recognize and attack invaders in the body such as viruses, bacteria, and cancer.

6 Jan 2021

Evidence review: COVID-19 infections are generally 'mild' in children under five years

Babies and asymptomatic cases account for up to half of COVID-19 infections in the under-five age group, which has implications for vaccination programs, a new UNSW study has found.

6 Jan 2021

Researchers claim SARS-CoV-2 B.1.1.7 variant likely to become globally dominant

The new variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detected in England replicates more than two times faster than the earlier strains. This replication advantage promises to make it the dominant global variant very shortly. This finding comes from a startling preprint that appeared on the medRxiv* server in December 2020.

6 Jan 2021

Copper surfaces can inactivate SARS-CoV-2 in as little as one minute, study finds

A new study by researchers at the University of Southampton, UK, has found that SARS-CoV-2 can inactivate on copper surfaces in as little as 1 minute. This is faster than the findings of previous studies in which it took as much as 4 hours before the virus was inactivated.

5 Jan 2021

P2 COVID-19 study shows no material safety differences between opaganib and control arms

Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material safety differences between opaganib and control arms.

4 Jan 2021

SARS-CoV-2 spike-antibody binding strength and hydrogen bond numbers are temperature dependent, study finds

A new preprint on the bioRxiv* server describes the interactions between the binding spike protein of the SARS-CoV-2 virus with the antibodies. Earlier studies have addressed the similarity in the 3D structures of the spike protein in the two SARS viruses as seen on cryo-EM.

24 Dec 2020

Higher BMI linked to increased risk of SARS-CoV-2 infection

Researchers at the University of Miami Miller School of Medicine, USA, revealed that the spike-specific immunoglobulin G antibodies in obese people are negatively associated with body mass index (BMI) and serum levels of proinflammatory and metabolic markers of pulmonary inflammation.

24 Dec 2020

SARS-CoV-2 infection increases risk of severe COVID-19 in pregnant women, newborns

Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection.

24 Dec 2020

Public adherence to COVID-19 guidelines in Norway: a case study

To evaluate and understand the adherence to public health actions recommended by the government, a team in Norway undertook a study funded in part by the Norwegian Research Council’s Centres of Excellence Funding Scheme and by the project: A realtime analytical pipeline for preparedness, planning, and response during the COVID-19 pandemic in Norway.

23 Dec 2020

At risk of extinction, black-footed ferrets get experimental COVID vaccine

In late summer, as researchers accelerated the first clinical trials of COVID-19 vaccines for humans, a group of scientists in Colorado worked to inoculate a far more fragile species.

23 Dec 2020

SARS-CoV-2 mutations may evade T cell immunity

A potentially disturbing new study suggests that SARS-CoV-2 may be undergoing strategic mutations that affect the host immune capacity to recognize and combat the pathogen via T effector cells.

23 Dec 2020

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.

23 Dec 2020

Study finds significantly lower mother-to-newborn transfer of anti-SARS-CoV-2 antibodies

Pregnant women may be especially vulnerable to developing more severe cases of COVID-19 following SARS-CoV-2 infection, but little is known about their anti-SARS-CoV-2 immune response or how it may affect their offspring.

22 Dec 2020

Cadmium linked to more severe flu and pneumonia infections

In this interview, News-Medical speaks to Dr. Howard Hu about his latest research into cadmium and how it could be causing more severe pneumonia infections.

22 Dec 2020

Comparing Google AI and human intelligence for the forecasting of COVID-19

Junko Kurita et al. from Japan have compared Google AI forecasting with a statistical model by human intelligence and recently presented it in a preprint medRxiv* paper.

22 Dec 2020

Pregnant women in third trimester unlikely to pass SARS-CoV-2 infection to newborns

A new study demonstrates that women in their third trimester are unlikely to pass a SARS-CoV-2 infection onto their babies.

22 Dec 2020

Study examines effects of social density and intention to vaccinate against COVID-19

Concerns over infecting others play a greater role in people's willingness to be vaccinated in sparsely populated areas than dense urban ones, according to newly published findings in the Proceedings of the National Academy of Sciences (PNAS) of the United States.

21 Dec 2020

Using data from wearables to characterize COVID-19 and influenza

By analyzing Fitbit data and self-reported symptoms, researchers from Evidation Health and collaborators analyzed trends in heart rate, step count, and symptom duration between patients with flu and those with COVID-19.

21 Dec 2020

New portable shield prevents spread of saliva and aerosols generated during dental procedures

Dental treatments are performed at close proximity to the mouths and noses of the patients, and the procedures are often related to the generation of aerosols as well as handling of oral fluids and blood. This puts dentists at a high risk of exposure to COVID-19, and other critical infectious diseases.

21 Dec 2020

Influenza News and Research

Latest Influenza News and Research

Low acceptance of COVID-19 vaccine among healthcare workers in USA

Scientists develop a new method to study the molecular characteristics of T cells

Evidence review: COVID-19 infections are generally 'mild' in children under five years

Researchers claim SARS-CoV-2 B.1.1.7 variant likely to become globally dominant

Copper surfaces can inactivate SARS-CoV-2 in as little as one minute, study finds

P2 COVID-19 study shows no material safety differences between opaganib and control arms

SARS-CoV-2 spike-antibody binding strength and hydrogen bond numbers are temperature dependent, study finds

Higher BMI linked to increased risk of SARS-CoV-2 infection

SARS-CoV-2 infection increases risk of severe COVID-19 in pregnant women, newborns

Public adherence to COVID-19 guidelines in Norway: a case study

At risk of extinction, black-footed ferrets get experimental COVID vaccine

SARS-CoV-2 mutations may evade T cell immunity

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Study finds significantly lower mother-to-newborn transfer of anti-SARS-CoV-2 antibodies

Cadmium linked to more severe flu and pneumonia infections

Comparing Google AI and human intelligence for the forecasting of COVID-19

Pregnant women in third trimester unlikely to pass SARS-CoV-2 infection to newborns

Study examines effects of social density and intention to vaccinate against COVID-19

Using data from wearables to characterize COVID-19 and influenza

New portable shield prevents spread of saliva and aerosols generated during dental procedures

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Influenza News and Research

Latest Influenza News and Research

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in